DUBLIN--(BUSINESS WIRE)--The "Hemostat Market in Korea 2020" report has been added to ResearchAndMarkets.com's offering.

The hemostat market is one of the fastest-growing markets in Korea. This report provides a comprehensive analysis including potential market assessment, market opportunities, competitive landscapes, marketing strategies, and the latest trends.

With this single report, you will be able to grasp the most comprehensive and up-to-date regulatory topics along with the current status of approval and reimbursement listing.

Plus, the report offers an additional suggestion regarding how to plan strategic access toward the market based on the in-depth analysis not only about its internal industry but also the external environment from the field professionals and business experts.

Companies Mentioned

• Abbott Korea Limited
• Bard Korea
• Baxter
• Cardical Health Korea
• Curesys
• DalimTissen
• Green Cross Corp
• Hanmi Healthcare
• Hyundai pharm
• Johnson& Johnson Medical
• Nano Pharm
• SK Plasma
• Samyang Biopharm
• Terumo Korea Corporation Co.,Ltd.

Key Topics Covered:

1 INTRODUCTION

1.1 Purpose

1.2 Utilization of Benefits

1.3 Scope

1.4 Market Segmentation

1.5 Definition

1.6 Research Method

1.6.1 Secondary Research

1.6.2 Primary Research

1.7 Analysis and Estimation Methods

1.7.1 Market Size Price Standard by Data Source

1.7.2 Exchange Rate

1.7.3 Market Size Estimation Methods

1.7.3.1 Reimbursement Size Estimation Methods

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

3.1 Total Market

3.1.1 5-Year Forecast

3.2 Use Volume of Hemostats by Medical Institutions

3.2.1 Total Hemostatic Products Market

3.2.2 Surgeries, Hemostatic Product Market

3.2.2.1 Hemostatic Product Market, By Medical Department

3.2.2.2 Hemostatic Product Market, By End User Type

3.2.3 Postoperative Vascular Intervention Hemostatic Product Market Product

4 MAJOR SUPPLIER STATUS

4.1 Baxter

4.2 Hyundai Pharm

4.3 GC Pharma

4.4 Johnson & Johnson Medical Korea Ltd

4.5 Dalim Tissen Co.,Ltd

4.6 Hanmi Healthcare Inc

4.7 Samyang Biopharm

4.8 Bard Korea

4.9 Curesys

4.10 Nano Pharm

4.11 SK Plasma Co., Ltd.

5 MARKET DYNAMICS

5.1 Counter Healthcare Key Indicators

5.1.1 Historical Overview and Prospects for Market Development

5.1.2 Historical Overview of Payment Environment

5.1.3 Number of Medical institutions in Korea

5.1.4 Reimbursement and Non-Reimbursement Classifications of Hemostats

5.2 Recent Trends in Key Indicators of Hemostats Market Size

5.2.1 Aging Population

5.2.2 Number of Surgical Procedures

5.2.3 Number of Endoscopic Surgery

5.2.4 Robotic Surgery

5.2.5 Number of Cancer Patients

5.2.6 Trauma Center

5.2.7 Number of Foreign Patients

5.3 Market Drivers

5.3.1 Main Indicator

5.3.2 Supply

5.4 Opportunity

5.4.1 Increasing Demand due to Increase in Number of Surgeries

5.4.2 Coverage Expansion of National Health Insurance Policy

5.4.3 Hemostats with Innovative Features

5.4.4 Clinical Study on Hemostats Treatment Technology

5.5 Threat

5.5.1 Revaluation of Reimbursement Prices

5.5.2 Expansion of Diagnosis Related Group (DRG) and New Diagnosis Related Group (nDRG)

5.6 Unmet Needs

For more information about this report visit https://www.researchandmarkets.com/r/g1rckf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900